Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Ancell
DR3 (human)-muIg Fusion Protein
551
CHF
CHF 551.00
In stock
ANC-528-02025 µgCHF 551.00
| Product Details | |
|---|---|
| Synonyms | TRAMP; Apo-3; Death Receptor 3; WSL-1; Lymphocyte-associated Receptor of Death; LARD; Tumor Necrosis Factor Receptor Superfamily Member 25; TNFRSF25 |
| Product Type | Protein |
| Properties | |
| Source/Host | CHO cells |
| Application |
ELISA |
| Formulation | 50 mM Sodium Phosphate pH 7.5, 100 mM Potassium Chloride, 150mM NaCl, 0.5mg/ml Gentamicin sulfate |
| Protein Negative Control | |
| Other Product Data |
Click here for Original Manufacturer Product Datasheet |
| Declaration | Manufactured by Ancell Corporation. |
| Shipping and Handling | |
| Shipping | BLUE ICE |
| Short Term Storage | +4°C |
| Long Term Storage | +4°C |
| Handling Advice | Avoid freeze/thaw cycles. |
| Use/Stability | Stable for at least 6 months after receipt when stored at +4°C. |
| Documents | |
| MSDS | Inquire |
| Product Specification Sheet | |
| Datasheet |
 Download PDF |
Description
Human DR3 (TRAMP; LARD) was designated TNF receptor superfamily member 25. TL1A is a ligand which can induce apoptosis through a cytoplasmic death domain similar to the CD178-CD95 (FasL-Fas) interaction. Alternatively, engagement of DR3 on T cells can synergize with other activating signals to enhance IFNγ production.
Related Products
